Acute Graft Versus Host Disease - 162 Studies Found

Recruiting : Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
: Graft vs Host Disease
: 2015-07-14
: Drug: Pregnyl® ARM 1: High-Risk aGVHD
Recruiting : A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
: Graft Versus Host Disease
: 2016-10-24
:
  • Biological: GLASSIA Other Name
Active, not recruiting : Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
:
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Previously Treated Myelodysplast
    : 2005-03-03
    :
    • Drug: Fludarabine Phosphate Gi
Completed : Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
: Stem Cell Transplantation
: 2008-01-29
:
  • Drug: tacrolimus Tacrolimus wi
Recruiting : Study of PRO 140 for Prophylaxis of Acute GVHD in Patients With AML or MDS Undergoing Allogeneic Stem-Cell Transplant.
:
  • Graft vs Host Disease
  • Leukemia, Myeloid, Acute
  • Myelodyspla
    : 2016-03-29
    :
    • Drug: PRO 140 Two 1 mL injecti
Recruiting : Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
:
  • Graft Versus Host Disease
  • Hematological Malignancies

: 2007-09-04
: Biological: ApoCell Three subjects per cohort will be treated with ApoCell according to an escalating sc
Recruiting : Gut Decontamination In Pediatric Allogeneic Hematopoietic
:
  • Hematopoietic Stem Cell Transplantation (HSCT)
  • Acute GVH Disease : 2015-11-16
    : Drug: Vancomycin-polymyxin B
Completed : Photochemotherapy and Graft-versus-leukemia in Acute-leukemia
:
  • ALL
  • AML
  • Acute GVHD
  • : 2015-09-08
    : Radiation: Photochemotherapy Oral 8-Methoxypsoralene (8-MOP), (0.4-0.8 mg/kg), are given 1.5-2 hours bef
Completed : Keratinocyte Growth Factor to Prevent Acute GVHD
: Graft-vs-Host Disease
: 2002-02-26
: Drug: Recombinant Human Keratinocyte Growth Factor (rHuKGF)
Recruiting : Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD
:
  • Peripheral Blood Stem Cell Transplantation
  • aGVHD

: 2016-07-26
: Drug: VPA Valproic acid with 1000mg loading dose with 500mg q12 4 hours later to maintain a trough level
<<< Previous | Next >>>